Form D Explorer
Angiex, Inc. · CIK 1710380

Report a data issueCitable research briefCompare issuerPrivate research collection

Angiex, Inc.

CIK 1710380 · Corporation · Inc. DELAWARE · CAMBRIDGE, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Aug 14, 2025
through Sep 26, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldAug 14, 2025 · DSep 26, 2025 · D/ALater minus earlier
Reported offering amount$20,284,497$28,409,510$8,125,013
Reported amount sold$10,980,030$21,991,695$11,011,665
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001710380-25-000003 · Later SEC source: 0001710380-25-000005

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Sep 26, 2025

Reported offering amount
$28,409,510
Reported exemptions
Rule 506(c)
Reported amount sold
$21,991,695

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)